0

Osanetant

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP160492568
CAS160492-56-8
Structure
Molecular Weight606.62
Description≥98% (HPLC)
SolubilityDMSO: 15 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Gateways to Clinical Trials

M Bayes, X Rabasseda, J R Prous

Methods Find Exp Clin Pharmacol. 2002 Apr;24(3):159-84.

PMID: 12087878

1

Identification of a Critical Residue in the Transmembrane Domain 2 of Tachykinin Neurokinin 3 Receptor Affecting the Dissociation Kinetics and Antagonism Mode of Osanetant (SR 142801) and Piperidine-Based Structures

Pari Malherbe, Claudia Kratzeisen, Anne Marcuz, Marie-Thérèse Zenner, Matthias H Nettekoven, Hasane Ratni, Joseph G Wettstein, Caterina Bissantz

J Med Chem. 2009 Nov 26;52(22):7103-12.

PMID: 19817444

1

Me-talnetant and Osanetant Interact Within Overlapping but Not Identical Binding Pockets in the Human Tachykinin Neurokinin 3 Receptor Transmembrane Domains

Pari Malherbe, Caterina Bissantz, Anne Marcuz, Claudia Kratzeisen, Marie-Thérèse Zenner, Joseph G Wettstein, Hasane Ratni, Claus Riemer, Will Spooren

Mol Pharmacol. 2008 Jun;73(6):1736-50.

PMID: 18308898

1

Neurokinin-3 Receptor-Specific Antagonists Talnetant and Osanetant Show Distinct Mode of Action in Cellular Ca2+ Mobilization but Display Similar Binding Kinetics and Identical Mechanism of Binding in Ligand Cross-Competition

Gaochao Tian, Dee Wilkins, Clay W Scott

Mol Pharmacol. 2007 Mar;71(3):902-11.

PMID: 17172464

1

Osanetant Sanofi-Synthélabo

F Kamali

Curr Opin Investig Drugs. 2001 Jul;2(7):950-6.

PMID: 11757797

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode